Abstract:Background: The relationship between Helicobacter pylori (H. pylori) infection and metabolic dysfunction-associated steatotic liver disease (MASLD) has attracted increased clinical attention. However, most of those current studies involve cross-sectional studies and meta-analyses, and experimental mechanistic exploration still needs to be improved. This study aimed to investigate the mechanisms by which H. pylori impacts MASLD. Methods: We established two H. pylori-infected (Cag A positive and Cag A negative) mouse models with 16 weeks of chow diet (CD) or high-fat diet (HFD) feeding. Body weight, liver triglyceride, blood glucose, serum biochemical parameters, inflammatory factors, and insulin resistance were measured, and histological analysis of liver tissues was performed. Mouse livers were subjected to transcriptome RNA sequencing analysis. Results: Although H. pylori infection could not significantly affect serum inflammatory factor levels and serum biochemical parameters in mice, serum insulin and homeostatic model assessment for insulin resistance levels increased in CD mode. In contrast, H. pylori Cag A + infection significantly aggravated hepatic pathological steatosis induced by HFD and elevated serum inflammatory factors and lipid metabolism parameters. Hepatic transcriptomic analysis in the CD groups revealed 767 differentially expressed genes (DEGs) in the H. pylori Cag A + infected group and 1473 DEGs in the H. pylori Cag A- infected group, and the "nonalcoholic fatty liver disease" pathway was significantly enriched in KEGG analysis. There were 578 DEGs in H. pylori Cag A + infection combined with the HFD feeding group and 820 DEGs in the H. pylori Cag A- infected group. DEGs in the HFD groups were significantly enriched in "fatty acid degradation" and "PPAR pathway." Exploring the effect of different Cag A statuses on mouse liver revealed that fatty acid binding protein 5 was differentially expressed in Cag A- H. pylori. DEG enrichment pathways were concentrated in the "PPAR pathway" and "fatty acid degradation." Conclusions: Clinicians are expected to comprehend the impact of H. pylori on MASLD and better understand and manage MASLD. H. pylori infection may exacerbate the development of MASLD by regulating hepatic lipid metabolism, and the H. pylori virulence factor Cag A plays a vital role in this regulation.

Ampk Alpha Pathway Involved In Hepatic Triglyceride Metabolism Disorder In Diet-Induced Obesity Mice Following Escherichia Coli Infection

Effects of intranasal Escherichia coli on glucolipid metabolism in high-fat diet-induced obese mice

Hepatic histopathology and apoptosis in diet-induced-obese mice under pneumonia.

Attenuated Cardiac oxidative stress, inflammation and apoptosis in Obese Mice with nonfatal infection of<i> Escherichia</i><i> coli</i>

Histopathological Changes Caused by Inflammation and Oxidative Stress in Diet-Induced-Obese Mouse Following Experimental Lung Injury

Diet-Induced Obesity Mice Execute Pulmonary Cell Apoptosis Via Death Receptor and ER-Stress Pathways after E. Coli Infection

Expression Pattern of Hepcidin in E.coli Challenged Obese Mice (IRM9P.600)

Delayed Pulmonary Apoptosis of Diet-Induced Obesity Mice Following Escherichia Coli Infection Through the Mitochondrial Apoptotic Pathway

Heat-Killed Enterococcus faecalis EF-2001 Attenuate Lipid Accumulation in Diet-Induced Obese (DIO) Mice by Activating AMPK Signaling in Liver

Microarray Analysis of lncRNA and mRNA Reveals Enhanced Lipolysis Along With Metabolic Remodeling in Mice Infected With Larval Echinococcus granulosus

Diet‐induced Obese Mice Exhibit Altered Immune Responses to Acute Lung Injury Induced by Escherichia Coli

Retraction Note: Effect of Intranasal Instillation of Escherichia Coli on Apoptosis of Spleen Cells in Diet-Induced-obese Mice

The Effects of New Selective PPARα Agonist CP775146 on Systematic Lipid Metabolism in Obese Mice and Its Potential Mechanism.

Obesity Enhances Antioxidant Capacity and Reduces Cytokine Levels of the Spleen in Mice to Resist Splenic Injury Challenged by Escherichia Coli

More Active Intestinal Immunity Developed by Obese Mice Than Non-Obese Mice After Challenged by <i>Escherichia coli</i>

Regulated Inflammation and Lipid Metabolism in Colon Mrna Expressions of Obese Germfree Mice Responding to Enterobacter Cloacae B29 Combined with the High Fat Diet

Trichinella spiralis infection ameliorated diet-induced obesity model in mice

Helicobacter pylori infection exacerbates metabolic dysfunction-associated steatotic liver disease through lipid metabolic pathways: a transcriptomic study

Periodontal pathogen Fusobacterium nucleatum infection accelerates hepatic steatosis in high‐fat diet‐fed ApoE knockout mice by inhibiting Nrf2/Keap1 signaling

Effects of Schistosoma japonicum infection on the expression of Arg-1 and Fizz-1 proteins in liver tis-sues of mice with high-fat diet induced obesity

Helicobacter Pylori Infection Aggravates Diet-Induced Nonalcoholic Fatty Liver in Mice.